• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Spinal needles Market Trends

    ID: MRFR/MED/0709-HCR
    80 Pages
    Kinjoll Dey
    October 2025

    Spinal Needles Market Research Report Information By Type (Atraumatic Needles, Directional Spinal Needles, and Pencil-Point Needles), Application (Therapeutic and Diagnostic), End-User (Hospitals & Clinics, Diagnostic Centers, Research Laboratories, and Others), and Region (Americas, Europe, Asia-Pacific, and Middle East and Africa)—Forecast till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Spinal needles Market Infographic
    Purchase Options
    Compare License
    Summary Table of Contents Segmentation Download PDF

    Market Trends

    Key Emerging Trends in the Spinal needles Market

    The spinal needles market is seeing a surge in demand, principally determined by the rising inclination for minimally invasive spinal strategies. Patients and medical care experts the same are perceiving the advantages of systems that include more modest cuts, diminished recuperation times, and lower hazard of intricacies. Market patterns show a significant expansion in the commonness of spinal problems universally. Factors like stationary lifestyle, maturing populations, and a surge in external muscle conditions add to a higher frequency of spinal issues. This, thus, drives the demand for spinal needles utilized in demonstrative and helpful mediations. Generally connected with anesthesia organization, spinal needles are tracking down new and expanded applications. There is a developing pattern in using these needles for symptomatic purposes, like cerebrospinal fluid analysis, as well as remedial mediations like spinal infusions for torment management. This enhancement expands the market's extension and potential. The market is seeing an increased emphasis on understanding wellbeing, provoking makers to foster needles with highlights that limit the gamble of difficulties. This incorporates developments, for example, hurtful needle tips and innovations that improve ongoing imaging direction during methodology, guaranteeing precise needle arrangement. Developing markets are seeing critical interests in medical services foundation, prompting expanded admittance to cutting edge operations. As medical care offices in these locales update their capacities, the demand for spinal needles is probably going to observe a simultaneous rise, introducing growth open doors for market players. The spinal needles market, in the same way as other others, confronted difficulties during the Coronavirus pandemic. Disturbances in the production network, diminished elective techniques, and financial vulnerabilities affected market elements. In any case, as medical care frameworks settle, the market is giving indications of recuperation, with an emphasis on addressing repressed demand and adjusting to the new typical in medical services delivery.

    Author
    Kinjoll Dey
    Research Analyst Level I

    He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

    Get In Touch

    Leave a Comment

    FAQs

    What is the projected growth of the Spinal Needles market?

    The Spinal Needles market is the expected increase in total market value of 0.69 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

    What is the size of the Spinal Needles market?

    Spinal Needles market size was valued at approximately 0.33 billion USD in 2024. This figure will reach 0.69 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

    What is the CAGR of the Spinal Needles market?

    Spinal Needles market is expected to grow at a CAGR of 6.91% between 2025 and 2035.

    How much will the Spinal Needles market be worth by 2035?

    Spinal Needles market is expected to be worth of 0.69 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

    How will the Spinal Needles market perform over the next 10 years?

    Over the next 10 years the Spinal Needles market is expected to shift from usd billion 0.33 to 0.69 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

    Which region held the largest market share in the spinal needles market?

    The Americas spinal needles market held the largest market share during the study period.

    Who are the key players in the spinal needles market?

    Braun Melsungen AG (US), Stryker Corporation (US), Boston Scientific Corporation (US), Becton, Dickinson, and Company (US), Smith’s Medical (US),Myco Medical (US),Argon Medical (US),Exelint International, Co. (US).

    Which type had the largest market share in the spinal needles market?

    The pencil-point needles segment held the majority share in 2024 contributing to around 40% with respect to the Spinal Needles Market.

    Market Summary

    As per Market Research Future Analysis, the Spinal Needles Market was valued at USD 0.33 Billion in 2024 and is projected to grow to USD 0.69 Billion by 2035, with a CAGR of 6.91% from 2025 to 2035. The growth is driven by the increasing geriatric population and the rising prevalence of spinal disorders such as spinal stenosis and neurological conditions. The therapeutic application of spinal needles is expected to dominate the market, supported by advancements in clinical investigations and product innovations.

    Key Market Trends & Highlights

    Key trends influencing the Spinal Needles Market include the following:

    • The pencil-point needles segment held the majority share in 2021 due to effective deployment in clinical settings.
    • The therapeutic segment is projected to be the fastest-growing application from 2024 to 2032, driven by the need for direct analgesia delivery.
    • The hospitals & clinics segment dominated the end-user market in 2021 and is expected to grow rapidly due to increased patient monitoring.
    • The Americas market is expected to account for USD 0.09 Billion in 2021, with a CAGR over 6.50% during the study period.

    Market Size & Forecast

    2024 Market Size USD 0.33 Billion
    2035 Market Size USD 0.69 Billion
    CAGR (2024-2035) 6.91%
    Largest Regional Market Share in 2021 Americas.

    Major Players

    Major players in the Spinal Needles Market include Braun Melsungen AG, Stryker Corporation, Boston Scientific Corporation, Becton, Dickinson, and Company, Smith's Medical, Myco Medical, Argon Medical, and Exelint International, Co.

    Market Trends

    Increasing prevalence of spinal stenosis and neurological disorder

    Spinal stenosis is a medical condition characterized by the compression of nerve roots by several pathological factors related to cord dysfunction elicited by a combination of mechanical compression and degenerative instability. The symptom of spinal stenosis includes weakness, pain, and numbness.

    A research article published in the American Institute of Minimally Invasive Surgery (AIMIS) in 2018 describes that approximately 250,000-500,000 suffer from spinal stenosis representing 1 per 1000 persons older than 65 years and about 5 of every 1,000 persons older than 50 years in America. This rising aging population suffering from spinal stenosis clearly demands an effective surgical intervention. Thus, this factor boosts the market growth of spinal needles.

    Furthermore, an increasing number of neurological disorders also act as a driving factor for market growth. According to the data published in Front Range Spine and Neurosurgery in 2018, more than 600 neurological conditions have been identified, affecting hundreds of millions globally.

    The demand for spinal needles is anticipated to rise as advancements in medical technology enhance procedural efficacy and patient outcomes.

    U.S. Food and Drug Administration (FDA)

    Spinal needles Market Market Drivers

    Market Trends and Projections

    The Global Spinal Needles Market Industry exhibits promising growth trends, with projections indicating a market value of 0.33 USD Billion in 2024 and an anticipated increase to 0.72 USD Billion by 2035. The market is expected to experience a compound annual growth rate of 7.36% from 2025 to 2035, driven by various factors including technological advancements, demographic shifts, and the rising prevalence of spinal disorders. These trends suggest a robust future for the industry, as stakeholders adapt to the evolving healthcare landscape and the increasing demand for effective spinal interventions.

    Increase in Geriatric Population

    The global increase in the geriatric population is a critical factor influencing the Global Spinal Needles Market Industry. Older adults are more susceptible to spinal conditions, necessitating regular medical interventions. According to demographic studies, the proportion of individuals aged 65 and older is projected to rise significantly, leading to a higher demand for spinal procedures. This demographic shift is likely to drive the market's growth, as healthcare providers seek effective solutions for managing age-related spinal disorders. The market is expected to expand, with estimates suggesting a value of 0.72 USD Billion by 2035, reflecting the needs of this growing population.

    Rising Prevalence of Spinal Disorders

    The increasing incidence of spinal disorders globally drives demand within the Global Spinal Needles Market Industry. Conditions such as herniated discs, spinal stenosis, and degenerative disc disease are becoming more prevalent, necessitating effective diagnostic and therapeutic interventions. For instance, the World Health Organization indicates that back pain affects a significant portion of the global population, leading to a growing need for spinal procedures. This trend is expected to contribute to the market's growth, with projections estimating the market value to reach 0.33 USD Billion in 2024 and potentially 0.72 USD Billion by 2035.

    Expansion of Healthcare Infrastructure

    The ongoing expansion of healthcare infrastructure in developing regions is poised to impact the Global Spinal Needles Market Industry positively. As countries invest in healthcare facilities and services, access to advanced medical technologies, including spinal needles, is improving. This expansion is particularly evident in emerging economies, where increased healthcare spending is facilitating the adoption of modern medical practices. Enhanced access to healthcare services is likely to drive demand for spinal procedures, thereby contributing to market growth. The Global Spinal Needles Market is expected to benefit from this trend, aligning with the projected CAGR of 7.36% from 2025 to 2035.

    Technological Advancements in Needle Design

    Innovations in spinal needle technology are enhancing the efficacy and safety of spinal procedures, thereby propelling the Global Spinal Needles Market Industry. Modern spinal needles are designed with features such as improved ergonomics, reduced needle gauge, and enhanced visualization capabilities. These advancements not only minimize patient discomfort but also improve procedural outcomes. For example, the introduction of atraumatic needles has been shown to reduce complications associated with spinal anesthesia. As these technologies continue to evolve, they are likely to attract more healthcare providers, contributing to a projected CAGR of 7.36% from 2025 to 2035.

    Growing Demand for Minimally Invasive Procedures

    The shift towards minimally invasive surgical techniques is a significant driver for the Global Spinal Needles Market Industry. Patients increasingly prefer procedures that offer reduced recovery times and lower risks of complications. Spinal needles play a crucial role in these minimally invasive approaches, facilitating accurate interventions with less tissue damage. As healthcare systems worldwide adopt these techniques, the demand for specialized spinal needles is expected to rise. This trend aligns with the overall growth of the market, which is anticipated to reach 0.33 USD Billion in 2024, reflecting the changing landscape of surgical practices.

    Market Segment Insights

    Spinal Needles Type Insights

    The Spinal Needles Market segmentation, based on type, includes pencil-point needles, directional spinal needles, and pencil-point needles. The pencil-point needles segment is to hold the majority share in 2021 in the Spinal Needles Market revenue. This is due to the collective efforts of the organization/ universities to effectively deploy it.

    In addition, the role of CTMS in the campus-wide adoption was to support multi-dimensional investigations, cancer trials, and pharmaceutical research. Leading companies in the pharmaceutical industry use enterprise-wide types like impact CTMS.

    January 2021 Stryker Corporation (US) acquired OrthoSensor, Inc. (US), a market leader in providing digital care in musculoskeletal care and total joint replacement sensor technology. The move will help the company innovate novel treatments, in the spinal segment as well.

    Spinal Needles Application Insights

    The Spinal Needles Market segmentation is based on an application that includes, therapeutic, diagnostic. The therapeutic segment has dominated the market in 2021 and is projected to be the faster-growing segment during the forecast period, 2024-2032.

    This is because the spinal needles are used to inject analgesia and/or anesthetic directly into the cerebrospinal fluid. Spinal needles enter the cerebral spinal fluid (CSF) through the membranes surrounding the spinal cord. Some of the notable products in the spinal needle market include Sprotte spinal needle by Pajunk (Germany), Whitacre-Pencil point spinal anesthesia needle by Becton, Dickinson and Company (US), and Quincke spinal needle by Vygon SA (France). The utility of spinal needles is increasing with the recently increasing number of clinical investigations.

    Figure 2 SPINAL NEEDLES MARKET, BY TYPE, 2021 & 2032 (USD BILLION)

    Source Secondary Research, Primary Research, Market Research Future Database, and Analyst Review

    Spinal Needles End User Insights

    The Spinal Needles Market segmentation is based on end-user that includes hospitals & clinics, diagnostic centers, research laboratories, and others. The hospitals & clinics segment has dominated the market in 2021 and is projected to be the faster-growing segment during the forecast period, 2024-2032.

    This is due to the increasing number of patients getting monitored with spinal disorders. Since advanced and complete treatments are available in the hospital, patients normally prefer to get treated at the hospital. A spinal anesthetic is used for lower abdominal, pelvic, rectal, or lower extremity surgery. Clinics are also medical care centers that provide care for patients suffering from various neurodegenerative diseases.

    December 2020 Smiths Medical (US) launched its Portex EchoGlo needle portfolio which work for echogenic brightness under ultrasound and are designed to make medication delivery more efficient and accurate. This further improves the companies pain management product portfolio.

    Get more detailed insights about Spinal Needles Market Research Report-Forecast till 2035

    Regional Insights

    By Region, the study segments the market into Americas, Europe, Asia-Pacific, and the Middle East & Africa. The America spinal needles market is expected to account for USD 0.09 billion in 2021 and is expected to exhibit a CAGR over 6.50% during the study period. This is attributed to the rising number of patients suffering from spinal disorders.

    For instance, in September 2019, B. Braun (Germany) collaborated with Philips (Netherlands) to launch the Onvision needle tip tracking guidance solution which works in real-time for regional anaesthesia processes. This works in line with Philip’s ultrasound system, making anaesthesia processes safer and more accurate.

    Further, the major countries studied are the U.S., Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

    Figure 3 SPINAL NEEDLES BY REGION 2021 & 2020 (USD MILLION)SPINAL NEEDLES BY REGION 2021 & 2020

    Source Secondary Research, Primary Research, Market Research Future Database, and Analyst Review

    Europe spinal needles market is expected to account for the second-largest market share due to increasing older population and rising patient population. Additionally, improving government initiatives and increasing healthcare reforms, and rising demand for technologically innovative treatment drive the growth of the spinal needles market in Europe. Further, the Germany spinal needles market is expected to hold the largest market share during the study period, and the UK spinal needles market is expected to fastest-growing market in the European region. Furthermore, Spain spinal needles market held the 5th place for the market share.

    The Asia-Pacific spinal needles market is expected to grow at a healthy CAGR from 2024 to 2032. This is due to the due to the rising number of universities sponsoring clinical trials, increasing healthcare spending, multinational companies moving toward the developing nations, and setting operational set-ups are likely to drive the growth of the market, the region offers lucrative opportunities for players in the spinal needles market. Moreover, Japan’s spinal needles market is expected to hold the largest market share, and China spinal needles market is expected fastest-growing market in the Asia-Pacific region.

    For instance, Japan’s spinal needles environment has been a significant transformation. Businesses engaged in spinal needles have a greater need to be aware of the fast-changing environment in order to benefit from the expansion, making it to be the world leader in the market for the spinal needles market.

    The Middle East & Africa includes the Middle East, Africa. Nevertheless, due to a limited access and healthcare affordability among the population, particularly in Africa, the Middle East and Africa held the smallest proportion of the Spinal Needles Market.

    Key Players and Competitive Insights

    The Spinal Needles Market is characterized by the presence of many global, regional, and local vendors. The market is highly competitive, with all the players competing to gain market share. Intense competition, rapid technological advances, frequent changes in government policies, and environmental regulations are key factors that confront market growth. The vendors compete based on cost, quality, and reliability. It is decisive for the vendors to provide cost-efficient and high-quality products to survive and succeed in an intensely competitive market environment.

    The major players have adopted a strategy of obtaining regulatory approval from government agencies for their products and signing contracts and agreements to broaden their reach and reduce operational costs. In August 2020, B. Braun (Germany) received the US FDA approval for its Onvision ultrasound guidance needle tip tracking solution, aiming to drastically improve success rates in regional anesthesia procedures. In September 2019, B. Braun (Germany) collaborated with Philips (Netherlands) to launch the Onvision needle tip tracking guidance solution, which works in real-time for regional anesthesia processes.

    The Spinal Needles Market is extremely competitive, with players investing heavily in R&D to create product differentiation and gain a significant market share.

    Key Companies in the Spinal needles Market market include

    Industry Developments

    December 2020 Smiths Medical (US) launched its Portex EchoGlo needle portfolio which work for echogenic brightness under ultrasound and are designed to make medication delivery more efficient and accurate. This further improves the companies pain management product portfolio.

    September 2019 B. Braun (Germany) collaborated with Philips (Netherlands) to launch the Onvision needle tip tracking guidance solution which works in real-time for regional anaesthesia processes. This works in line with Philip’s ultrasound system, making anaesthesia processes safer and more accurate.

    January 2021 Stryker Corporation (US) acquired OrthoSensor, Inc. (US), a market leader in providing digital care in musculoskeletal care and total joint replacement sensor technology. The move will help the company innovate novel treatments, in the spinal segment as well.

    December 2020 Argon Medical (US) acquired Mana-Tech, Ltd. (UK) which was its exclusive product distributor in the UK and Ireland. This move helped the company to expand its reach throughout Europe.

    November 2020 Medtronic plc (Ireland) acquired Medicrea (France) to become the first company to provide Artificial Intelligence (AI) driven spinal surgery planning, implant, and robotic surgery with the help of Medicrea Ai capabilities.

    Future Outlook

    Spinal needles Market Future Outlook

    The Global Spinal Needles Market is projected to grow at a 6.91% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of spinal disorders, and rising demand for minimally invasive procedures.

    New opportunities lie in:

    • Develop innovative spinal needle designs to enhance patient safety and comfort.
    • Expand distribution networks in emerging markets to capture untapped customer bases.
    • Invest in digital health technologies for improved procedural guidance and training.

    By 2035, the market is expected to exhibit robust growth, reflecting advancements and increased adoption of spinal needle technologies.

    Market Segmentation

    Spinal Needles Type Outlook

    • Pencil-Point Needles
    • Directional Spinal Needles
    • Atraumatic Needles

    Spinal Needles End User Outlook

    • Hospitals & Clinics
    • Diagnostic Centers
    • Research Laboratories
    • Speciality Centres

    Spinal Needles Regional Outlook

    North America
    • Braun Melsungen AG (US)
    • Stryker Corporation (US)
    • Boston Scientific Corporation (US)
    • Becton, Dickinson, and Company (US)
    • Smith’s Medical (US)
    • Myco Medical (US)
    • Argon Medical (US)
    • Exelint International, Co. (US)
    • Pencil-Point Needles
    • Directional Spinal Needles
    • Atraumatic Needles
    • Therapeutic
    • Diagnostic
    • Hospitals & Clinics
    • Diagnostic Centers
    • Research Laboratories
    • Speciality Centres
    • US
    • Canada
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
    • Middle East
    • Africa

    Spinal Needles Application Outlook

    • Therapeutic
    • Diagnostic

    Report Scope

    Attribute/Metric Details
    Market Size 2024 USD 0.33 billion
    Market Size 2035 0.69
    Compound Annual Growth Rate (CAGR) 6.91% (2025 - 2035)
    Base Year 2024
    Forecast Period 2025 - 2035
    Historical Data 2018 & 2022
    Forecast Units Value (USD Billion)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Segments Covered Type, Application, End User, and Region
    Geographies Covered Americas, Europe, Asia Pacific, and Middle East and Africa
    Countries Covered The U.S, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
    Key Companies Profiled B. Braun Melsungen AG (US), Stryker Corporation (US), Boston Scientific Corporation (US), Becton, Dickinson, and Company (US) , Smiths Medical (US), Myco Medical (US),Argon Medical (US),Exelint International, Co. (US)
    Key Market Opportunities Increasing number of collaborations, acquisitions and product launches
    Key Market Dynamics Rising geriatric population prone to spinal disorders  Increasing application for spinal needles for spine surgeries
    Market Size 2025 0.35

    FAQs

    What is the projected growth of the Spinal Needles market?

    The Spinal Needles market is the expected increase in total market value of 0.69 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

    What is the size of the Spinal Needles market?

    Spinal Needles market size was valued at approximately 0.33 billion USD in 2024. This figure will reach 0.69 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

    What is the CAGR of the Spinal Needles market?

    Spinal Needles market is expected to grow at a CAGR of 6.91% between 2025 and 2035.

    How much will the Spinal Needles market be worth by 2035?

    Spinal Needles market is expected to be worth of 0.69 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

    How will the Spinal Needles market perform over the next 10 years?

    Over the next 10 years the Spinal Needles market is expected to shift from usd billion 0.33 to 0.69 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

    Which region held the largest market share in the spinal needles market?

    The Americas spinal needles market held the largest market share during the study period.

    Who are the key players in the spinal needles market?

    Braun Melsungen AG (US), Stryker Corporation (US), Boston Scientific Corporation (US), Becton, Dickinson, and Company (US), Smith’s Medical (US),Myco Medical (US),Argon Medical (US),Exelint International, Co. (US).

    Which type had the largest market share in the spinal needles market?

    The pencil-point needles segment held the majority share in 2024 contributing to around 40% with respect to the Spinal Needles Market.

    1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
      1. | 1.1 EXECUTIVE SUMMARY
      2. | | 1.1.1 Market Overview
      3. | | 1.1.2 Key Findings
      4. | | 1.1.3 Market Segmentation
      5. | | 1.1.4 Competitive Landscape
      6. | | 1.1.5 Challenges and Opportunities
      7. | | 1.1.6 Future Outlook
    2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
      1. | 2.1 MARKET INTRODUCTION
      2. | | 2.1.1 Definition
      3. | | 2.1.2 Scope of the study
      4. | | | 2.1.2.1 Research Objective
      5. | | | 2.1.2.2 Assumption
      6. | | | 2.1.2.3 Limitations
      7. | 2.2 RESEARCH METHODOLOGY
      8. | | 2.2.1 Overview
      9. | | 2.2.2 Data Mining
      10. | | 2.2.3 Secondary Research
      11. | | 2.2.4 Primary Research
      12. | | | 2.2.4.1 Primary Interviews and Information Gathering Process
      13. | | | 2.2.4.2 Breakdown of Primary Respondents
      14. | | 2.2.5 Forecasting Model
      15. | | 2.2.6 Market Size Estimation
      16. | | | 2.2.6.1 Bottom-Up Approach
      17. | | | 2.2.6.2 Top-Down Approach
      18. | | 2.2.7 Data Triangulation
      19. | | 2.2.8 Validation
    3. SECTION III: QUALITATIVE ANALYSIS
      1. | 3.1 MARKET DYNAMICS
      2. | | 3.1.1 Overview
      3. | | 3.1.2 Drivers
      4. | | 3.1.3 Restraints
      5. | | 3.1.4 Opportunities
      6. | 3.2 MARKET FACTOR ANALYSIS
      7. | | 3.2.1 Value chain Analysis
      8. | | 3.2.2 Porter's Five Forces Analysis
      9. | | | 3.2.2.1 Bargaining Power of Suppliers
      10. | | | 3.2.2.2 Bargaining Power of Buyers
      11. | | | 3.2.2.3 Threat of New Entrants
      12. | | | 3.2.2.4 Threat of Substitutes
      13. | | | 3.2.2.5 Intensity of Rivalry
      14. | | 3.2.3 COVID-19 Impact Analysis
      15. | | | 3.2.3.1 Market Impact Analysis
      16. | | | 3.2.3.2 Regional Impact
      17. | | | 3.2.3.3 Opportunity and Threat Analysis
    4. SECTION IV: QUANTITATIVE ANALYSIS
      1. | 4.1 Healthcare, BY Type (USD Billion)
      2. | | 4.1.1 Pencil-Point Needles
      3. | | 4.1.2 Directional Spinal Needles
      4. | | 4.1.3 Atraumatic Needles
      5. | 4.2 Healthcare, BY Application (USD Billion)
      6. | | 4.2.1 Therapeutic
      7. | | 4.2.2 Diagnostic
      8. | 4.3 Healthcare, BY End User (USD Billion)
      9. | | 4.3.1 Hospitals & Clinics
      10. | | 4.3.2 Diagnostic Centers
      11. | | 4.3.3 Research Laboratories
      12. | | 4.3.4 Speciality Centres
      13. | 4.4 Healthcare, BY Region (USD Billion)
      14. | | 4.4.1 North America
      15. | | | 4.4.1.1 US
      16. | | | 4.4.1.2 Canada
      17. | | 4.4.2 Europe
      18. | | | 4.4.2.1 Germany
      19. | | | 4.4.2.2 UK
      20. | | | 4.4.2.3 France
      21. | | | 4.4.2.4 Russia
      22. | | | 4.4.2.5 Italy
      23. | | | 4.4.2.6 Spain
      24. | | | 4.4.2.7 Rest of Europe
      25. | | 4.4.3 APAC
      26. | | | 4.4.3.1 China
      27. | | | 4.4.3.2 India
      28. | | | 4.4.3.3 Japan
      29. | | | 4.4.3.4 South Korea
      30. | | | 4.4.3.5 Malaysia
      31. | | | 4.4.3.6 Thailand
      32. | | | 4.4.3.7 Indonesia
      33. | | | 4.4.3.8 Rest of APAC
      34. | | 4.4.4 South America
      35. | | | 4.4.4.1 Brazil
      36. | | | 4.4.4.2 Mexico
      37. | | | 4.4.4.3 Argentina
      38. | | | 4.4.4.4 Rest of South America
      39. | | 4.4.5 MEA
      40. | | | 4.4.5.1 GCC Countries
      41. | | | 4.4.5.2 South Africa
      42. | | | 4.4.5.3 Rest of MEA
    5. SECTION V: COMPETITIVE ANALYSIS
      1. | 5.1 Competitive Landscape
      2. | | 5.1.1 Overview
      3. | | 5.1.2 Competitive Analysis
      4. | | 5.1.3 Market share Analysis
      5. | | 5.1.4 Major Growth Strategy in the Healthcare
      6. | | 5.1.5 Competitive Benchmarking
      7. | | 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      8. | | 5.1.7 Key developments and growth strategies
      9. | | | 5.1.7.1 New Product Launch/Service Deployment
      10. | | | 5.1.7.2 Merger & Acquisitions
      11. | | | 5.1.7.3 Joint Ventures
      12. | | 5.1.8 Major Players Financial Matrix
      13. | | | 5.1.8.1 Sales and Operating Income
      14. | | | 5.1.8.2 Major Players R&D Expenditure. 2023
      15. | 5.2 Company Profiles
      16. | | 5.2.1 B. Braun Melsungen AG (DE)
      17. | | | 5.2.1.1 Financial Overview
      18. | | | 5.2.1.2 Products Offered
      19. | | | 5.2.1.3 Key Developments
      20. | | | 5.2.1.4 SWOT Analysis
      21. | | | 5.2.1.5 Key Strategies
      22. | | 5.2.2 Medtronic plc (IE)
      23. | | | 5.2.2.1 Financial Overview
      24. | | | 5.2.2.2 Products Offered
      25. | | | 5.2.2.3 Key Developments
      26. | | | 5.2.2.4 SWOT Analysis
      27. | | | 5.2.2.5 Key Strategies
      28. | | 5.2.3 Teleflex Incorporated (US)
      29. | | | 5.2.3.1 Financial Overview
      30. | | | 5.2.3.2 Products Offered
      31. | | | 5.2.3.3 Key Developments
      32. | | | 5.2.3.4 SWOT Analysis
      33. | | | 5.2.3.5 Key Strategies
      34. | | 5.2.4 Smiths Medical (US)
      35. | | | 5.2.4.1 Financial Overview
      36. | | | 5.2.4.2 Products Offered
      37. | | | 5.2.4.3 Key Developments
      38. | | | 5.2.4.4 SWOT Analysis
      39. | | | 5.2.4.5 Key Strategies
      40. | | 5.2.5 Halyard Health, Inc. (US)
      41. | | | 5.2.5.1 Financial Overview
      42. | | | 5.2.5.2 Products Offered
      43. | | | 5.2.5.3 Key Developments
      44. | | | 5.2.5.4 SWOT Analysis
      45. | | | 5.2.5.5 Key Strategies
      46. | | 5.2.6 Stryker Corporation (US)
      47. | | | 5.2.6.1 Financial Overview
      48. | | | 5.2.6.2 Products Offered
      49. | | | 5.2.6.3 Key Developments
      50. | | | 5.2.6.4 SWOT Analysis
      51. | | | 5.2.6.5 Key Strategies
      52. | | 5.2.7 Boston Scientific Corporation (US)
      53. | | | 5.2.7.1 Financial Overview
      54. | | | 5.2.7.2 Products Offered
      55. | | | 5.2.7.3 Key Developments
      56. | | | 5.2.7.4 SWOT Analysis
      57. | | | 5.2.7.5 Key Strategies
      58. | | 5.2.8 Nipro Corporation (JP)
      59. | | | 5.2.8.1 Financial Overview
      60. | | | 5.2.8.2 Products Offered
      61. | | | 5.2.8.3 Key Developments
      62. | | | 5.2.8.4 SWOT Analysis
      63. | | | 5.2.8.5 Key Strategies
      64. | 5.3 Appendix
      65. | | 5.3.1 References
      66. | | 5.3.2 Related Reports
    6. LIST OF FIGURES
      1. | 6.1 MARKET SYNOPSIS
      2. | 6.2 NORTH AMERICA MARKET ANALYSIS
      3. | 6.3 US MARKET ANALYSIS BY TYPE
      4. | 6.4 US MARKET ANALYSIS BY APPLICATION
      5. | 6.5 US MARKET ANALYSIS BY END USER
      6. | 6.6 CANADA MARKET ANALYSIS BY TYPE
      7. | 6.7 CANADA MARKET ANALYSIS BY APPLICATION
      8. | 6.8 CANADA MARKET ANALYSIS BY END USER
      9. | 6.9 EUROPE MARKET ANALYSIS
      10. | 6.10 GERMANY MARKET ANALYSIS BY TYPE
      11. | 6.11 GERMANY MARKET ANALYSIS BY APPLICATION
      12. | 6.12 GERMANY MARKET ANALYSIS BY END USER
      13. | 6.13 UK MARKET ANALYSIS BY TYPE
      14. | 6.14 UK MARKET ANALYSIS BY APPLICATION
      15. | 6.15 UK MARKET ANALYSIS BY END USER
      16. | 6.16 FRANCE MARKET ANALYSIS BY TYPE
      17. | 6.17 FRANCE MARKET ANALYSIS BY APPLICATION
      18. | 6.18 FRANCE MARKET ANALYSIS BY END USER
      19. | 6.19 RUSSIA MARKET ANALYSIS BY TYPE
      20. | 6.20 RUSSIA MARKET ANALYSIS BY APPLICATION
      21. | 6.21 RUSSIA MARKET ANALYSIS BY END USER
      22. | 6.22 ITALY MARKET ANALYSIS BY TYPE
      23. | 6.23 ITALY MARKET ANALYSIS BY APPLICATION
      24. | 6.24 ITALY MARKET ANALYSIS BY END USER
      25. | 6.25 SPAIN MARKET ANALYSIS BY TYPE
      26. | 6.26 SPAIN MARKET ANALYSIS BY APPLICATION
      27. | 6.27 SPAIN MARKET ANALYSIS BY END USER
      28. | 6.28 REST OF EUROPE MARKET ANALYSIS BY TYPE
      29. | 6.29 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
      30. | 6.30 REST OF EUROPE MARKET ANALYSIS BY END USER
      31. | 6.31 APAC MARKET ANALYSIS
      32. | 6.32 CHINA MARKET ANALYSIS BY TYPE
      33. | 6.33 CHINA MARKET ANALYSIS BY APPLICATION
      34. | 6.34 CHINA MARKET ANALYSIS BY END USER
      35. | 6.35 INDIA MARKET ANALYSIS BY TYPE
      36. | 6.36 INDIA MARKET ANALYSIS BY APPLICATION
      37. | 6.37 INDIA MARKET ANALYSIS BY END USER
      38. | 6.38 JAPAN MARKET ANALYSIS BY TYPE
      39. | 6.39 JAPAN MARKET ANALYSIS BY APPLICATION
      40. | 6.40 JAPAN MARKET ANALYSIS BY END USER
      41. | 6.41 SOUTH KOREA MARKET ANALYSIS BY TYPE
      42. | 6.42 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
      43. | 6.43 SOUTH KOREA MARKET ANALYSIS BY END USER
      44. | 6.44 MALAYSIA MARKET ANALYSIS BY TYPE
      45. | 6.45 MALAYSIA MARKET ANALYSIS BY APPLICATION
      46. | 6.46 MALAYSIA MARKET ANALYSIS BY END USER
      47. | 6.47 THAILAND MARKET ANALYSIS BY TYPE
      48. | 6.48 THAILAND MARKET ANALYSIS BY APPLICATION
      49. | 6.49 THAILAND MARKET ANALYSIS BY END USER
      50. | 6.50 INDONESIA MARKET ANALYSIS BY TYPE
      51. | 6.51 INDONESIA MARKET ANALYSIS BY APPLICATION
      52. | 6.52 INDONESIA MARKET ANALYSIS BY END USER
      53. | 6.53 REST OF APAC MARKET ANALYSIS BY TYPE
      54. | 6.54 REST OF APAC MARKET ANALYSIS BY APPLICATION
      55. | 6.55 REST OF APAC MARKET ANALYSIS BY END USER
      56. | 6.56 SOUTH AMERICA MARKET ANALYSIS
      57. | 6.57 BRAZIL MARKET ANALYSIS BY TYPE
      58. | 6.58 BRAZIL MARKET ANALYSIS BY APPLICATION
      59. | 6.59 BRAZIL MARKET ANALYSIS BY END USER
      60. | 6.60 MEXICO MARKET ANALYSIS BY TYPE
      61. | 6.61 MEXICO MARKET ANALYSIS BY APPLICATION
      62. | 6.62 MEXICO MARKET ANALYSIS BY END USER
      63. | 6.63 ARGENTINA MARKET ANALYSIS BY TYPE
      64. | 6.64 ARGENTINA MARKET ANALYSIS BY APPLICATION
      65. | 6.65 ARGENTINA MARKET ANALYSIS BY END USER
      66. | 6.66 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE
      67. | 6.67 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
      68. | 6.68 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
      69. | 6.69 MEA MARKET ANALYSIS
      70. | 6.70 GCC COUNTRIES MARKET ANALYSIS BY TYPE
      71. | 6.71 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
      72. | 6.72 GCC COUNTRIES MARKET ANALYSIS BY END USER
      73. | 6.73 SOUTH AFRICA MARKET ANALYSIS BY TYPE
      74. | 6.74 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
      75. | 6.75 SOUTH AFRICA MARKET ANALYSIS BY END USER
      76. | 6.76 REST OF MEA MARKET ANALYSIS BY TYPE
      77. | 6.77 REST OF MEA MARKET ANALYSIS BY APPLICATION
      78. | 6.78 REST OF MEA MARKET ANALYSIS BY END USER
      79. | 6.79 KEY BUYING CRITERIA OF HEALTHCARE
      80. | 6.80 RESEARCH PROCESS OF MRFR
      81. | 6.81 DRO ANALYSIS OF HEALTHCARE
      82. | 6.82 DRIVERS IMPACT ANALYSIS: HEALTHCARE
      83. | 6.83 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
      84. | 6.84 SUPPLY / VALUE CHAIN: HEALTHCARE
      85. | 6.85 HEALTHCARE, BY TYPE, 2024 (% SHARE)
      86. | 6.86 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Billion)
      87. | 6.87 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
      88. | 6.88 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
      89. | 6.89 HEALTHCARE, BY END USER, 2024 (% SHARE)
      90. | 6.90 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
      91. | 6.91 BENCHMARKING OF MAJOR COMPETITORS
    7. LIST OF TABLES
      1. | 7.1 LIST OF ASSUMPTIONS
      2. | | 7.1.1
      3. | 7.2 North America MARKET SIZE ESTIMATES; FORECAST
      4. | | 7.2.1 BY TYPE, 2025-2035 (USD Billion)
      5. | | 7.2.2 BY APPLICATION, 2025-2035 (USD Billion)
      6. | | 7.2.3 BY END USER, 2025-2035 (USD Billion)
      7. | 7.3 US MARKET SIZE ESTIMATES; FORECAST
      8. | | 7.3.1 BY TYPE, 2025-2035 (USD Billion)
      9. | | 7.3.2 BY APPLICATION, 2025-2035 (USD Billion)
      10. | | 7.3.3 BY END USER, 2025-2035 (USD Billion)
      11. | 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
      12. | | 7.4.1 BY TYPE, 2025-2035 (USD Billion)
      13. | | 7.4.2 BY APPLICATION, 2025-2035 (USD Billion)
      14. | | 7.4.3 BY END USER, 2025-2035 (USD Billion)
      15. | 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
      16. | | 7.5.1 BY TYPE, 2025-2035 (USD Billion)
      17. | | 7.5.2 BY APPLICATION, 2025-2035 (USD Billion)
      18. | | 7.5.3 BY END USER, 2025-2035 (USD Billion)
      19. | 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
      20. | | 7.6.1 BY TYPE, 2025-2035 (USD Billion)
      21. | | 7.6.2 BY APPLICATION, 2025-2035 (USD Billion)
      22. | | 7.6.3 BY END USER, 2025-2035 (USD Billion)
      23. | 7.7 UK MARKET SIZE ESTIMATES; FORECAST
      24. | | 7.7.1 BY TYPE, 2025-2035 (USD Billion)
      25. | | 7.7.2 BY APPLICATION, 2025-2035 (USD Billion)
      26. | | 7.7.3 BY END USER, 2025-2035 (USD Billion)
      27. | 7.8 France MARKET SIZE ESTIMATES; FORECAST
      28. | | 7.8.1 BY TYPE, 2025-2035 (USD Billion)
      29. | | 7.8.2 BY APPLICATION, 2025-2035 (USD Billion)
      30. | | 7.8.3 BY END USER, 2025-2035 (USD Billion)
      31. | 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
      32. | | 7.9.1 BY TYPE, 2025-2035 (USD Billion)
      33. | | 7.9.2 BY APPLICATION, 2025-2035 (USD Billion)
      34. | | 7.9.3 BY END USER, 2025-2035 (USD Billion)
      35. | 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
      36. | | 7.10.1 BY TYPE, 2025-2035 (USD Billion)
      37. | | 7.10.2 BY APPLICATION, 2025-2035 (USD Billion)
      38. | | 7.10.3 BY END USER, 2025-2035 (USD Billion)
      39. | 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
      40. | | 7.11.1 BY TYPE, 2025-2035 (USD Billion)
      41. | | 7.11.2 BY APPLICATION, 2025-2035 (USD Billion)
      42. | | 7.11.3 BY END USER, 2025-2035 (USD Billion)
      43. | 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
      44. | | 7.12.1 BY TYPE, 2025-2035 (USD Billion)
      45. | | 7.12.2 BY APPLICATION, 2025-2035 (USD Billion)
      46. | | 7.12.3 BY END USER, 2025-2035 (USD Billion)
      47. | 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
      48. | | 7.13.1 BY TYPE, 2025-2035 (USD Billion)
      49. | | 7.13.2 BY APPLICATION, 2025-2035 (USD Billion)
      50. | | 7.13.3 BY END USER, 2025-2035 (USD Billion)
      51. | 7.14 China MARKET SIZE ESTIMATES; FORECAST
      52. | | 7.14.1 BY TYPE, 2025-2035 (USD Billion)
      53. | | 7.14.2 BY APPLICATION, 2025-2035 (USD Billion)
      54. | | 7.14.3 BY END USER, 2025-2035 (USD Billion)
      55. | 7.15 India MARKET SIZE ESTIMATES; FORECAST
      56. | | 7.15.1 BY TYPE, 2025-2035 (USD Billion)
      57. | | 7.15.2 BY APPLICATION, 2025-2035 (USD Billion)
      58. | | 7.15.3 BY END USER, 2025-2035 (USD Billion)
      59. | 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
      60. | | 7.16.1 BY TYPE, 2025-2035 (USD Billion)
      61. | | 7.16.2 BY APPLICATION, 2025-2035 (USD Billion)
      62. | | 7.16.3 BY END USER, 2025-2035 (USD Billion)
      63. | 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
      64. | | 7.17.1 BY TYPE, 2025-2035 (USD Billion)
      65. | | 7.17.2 BY APPLICATION, 2025-2035 (USD Billion)
      66. | | 7.17.3 BY END USER, 2025-2035 (USD Billion)
      67. | 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
      68. | | 7.18.1 BY TYPE, 2025-2035 (USD Billion)
      69. | | 7.18.2 BY APPLICATION, 2025-2035 (USD Billion)
      70. | | 7.18.3 BY END USER, 2025-2035 (USD Billion)
      71. | 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
      72. | | 7.19.1 BY TYPE, 2025-2035 (USD Billion)
      73. | | 7.19.2 BY APPLICATION, 2025-2035 (USD Billion)
      74. | | 7.19.3 BY END USER, 2025-2035 (USD Billion)
      75. | 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
      76. | | 7.20.1 BY TYPE, 2025-2035 (USD Billion)
      77. | | 7.20.2 BY APPLICATION, 2025-2035 (USD Billion)
      78. | | 7.20.3 BY END USER, 2025-2035 (USD Billion)
      79. | 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
      80. | | 7.21.1 BY TYPE, 2025-2035 (USD Billion)
      81. | | 7.21.2 BY APPLICATION, 2025-2035 (USD Billion)
      82. | | 7.21.3 BY END USER, 2025-2035 (USD Billion)
      83. | 7.22 South America MARKET SIZE ESTIMATES; FORECAST
      84. | | 7.22.1 BY TYPE, 2025-2035 (USD Billion)
      85. | | 7.22.2 BY APPLICATION, 2025-2035 (USD Billion)
      86. | | 7.22.3 BY END USER, 2025-2035 (USD Billion)
      87. | 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
      88. | | 7.23.1 BY TYPE, 2025-2035 (USD Billion)
      89. | | 7.23.2 BY APPLICATION, 2025-2035 (USD Billion)
      90. | | 7.23.3 BY END USER, 2025-2035 (USD Billion)
      91. | 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
      92. | | 7.24.1 BY TYPE, 2025-2035 (USD Billion)
      93. | | 7.24.2 BY APPLICATION, 2025-2035 (USD Billion)
      94. | | 7.24.3 BY END USER, 2025-2035 (USD Billion)
      95. | 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
      96. | | 7.25.1 BY TYPE, 2025-2035 (USD Billion)
      97. | | 7.25.2 BY APPLICATION, 2025-2035 (USD Billion)
      98. | | 7.25.3 BY END USER, 2025-2035 (USD Billion)
      99. | 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
      100. | | 7.26.1 BY TYPE, 2025-2035 (USD Billion)
      101. | | 7.26.2 BY APPLICATION, 2025-2035 (USD Billion)
      102. | | 7.26.3 BY END USER, 2025-2035 (USD Billion)
      103. | 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
      104. | | 7.27.1 BY TYPE, 2025-2035 (USD Billion)
      105. | | 7.27.2 BY APPLICATION, 2025-2035 (USD Billion)
      106. | | 7.27.3 BY END USER, 2025-2035 (USD Billion)
      107. | 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
      108. | | 7.28.1 BY TYPE, 2025-2035 (USD Billion)
      109. | | 7.28.2 BY APPLICATION, 2025-2035 (USD Billion)
      110. | | 7.28.3 BY END USER, 2025-2035 (USD Billion)
      111. | 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
      112. | | 7.29.1 BY TYPE, 2025-2035 (USD Billion)
      113. | | 7.29.2 BY APPLICATION, 2025-2035 (USD Billion)
      114. | | 7.29.3 BY END USER, 2025-2035 (USD Billion)
      115. | 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
      116. | | 7.30.1 BY TYPE, 2025-2035 (USD Billion)
      117. | | 7.30.2 BY APPLICATION, 2025-2035 (USD Billion)
      118. | | 7.30.3 BY END USER, 2025-2035 (USD Billion)
      119. | 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
      120. | | 7.31.1
      121. | 7.32 ACQUISITION/PARTNERSHIP
      122. | | 7.32.1

    Spinal Needles Market Segmentation

    Spinal Needles Models Type Outlook (USD Billion, 2018-2030)

    • Pencil-Point Needles
    • Directional Spinal Needles
    • Atraumatic Needles

    Spinal Needles Application Outlook (USD Billion, 2018-2030)

    • Therapeutic
    • Diagnostic

    Spinal Needles End User Outlook (USD Billion, 2018-2030)

    • Hospitals & Clinics
    • Diagnostic Centers
    • Research Laboratories
    • Speciality Centres

    Spinal Needles Regional Outlook (USD Billion, 2018-2030)

    • North America Outlook (USD Billion, 2018-2030)

      • North America Spinal Needles by Type
        • Pencil-Point Needles
        • Directional Spinal Needles
        • Atraumatic Needles

      • North America Spinal Needles by Application

        • Therapeutic
        • Diagnostic

      • North America Spinal Needles by End User

        • Hospitals & Clinics
        • Diagnostic Centers
        • Research Laboratories
        • Speciality Centres

      • US Outlook (USD Billion, 2018-2030)

      • US Spinal Needles by Type
        • Pencil-Point Needles
        • Directional Spinal Needles
        • Atraumatic Needles

      • US Spinal Needles by Application

        • Therapeutic
        • Diagnostic

      • US Spinal Needles by End User

        • Hospitals & Clinics
        • Diagnostic Centers
        • Research Laboratories
        • Speciality Centres

      • Canada Outlook (USD Billion, 2018-2030)

      • Canada Spinal Needles by Type

        • Pencil-Point Needles
        • Directional Spinal Needles
        • Atraumatic Needles

      • Canada Spinal Needles by Application

        • Therapeutic
        • Diagnostic

      • Canada Spinal Needles by End User

        • Hospitals & Clinics
        • Diagnostic Centers
        • Research Laboratories
        • Speciality Centres

    • Europe Outlook (USD Billion, 2018-2030)

      • Europe Spinal Needles by Type

        • Pencil-Point Needles
        • Directional Spinal Needles
        • Atraumatic Needles

      • Europe Spinal Needles by Application

        • Therapeutic
        • Diagnostic

      • Europe Spinal Needles by End User

        • Hospitals & Clinics
        • Diagnostic Centers
        • Research Laboratories
        • Speciality Centres

      • Germany Outlook (USD Billion, 2018-2030)

      • Germany Spinal Needles by Type

        • Pencil-Point Needles
        • Directional Spinal Needles
        • Atraumatic Needles

      • Germany Spinal Needles by Application

        • Therapeutic
        • Diagnostic

      • Germany Spinal Needles by End User

        • Hospitals & Clinics
        • Diagnostic Centers
        • Research Laboratories
        • Speciality Centres

      • France Outlook (USD Billion, 2018-2030)

      • France Spinal Needles by Type

        • Pencil-Point Needles
        • Directional Spinal Needles
        • Atraumatic Needles

      • France Spinal Needles by Application

        • Therapeutic
        • Diagnostic

      • France Spinal Needles by End User

        • Hospitals & Clinics
        • Diagnostic Centers
        • Research Laboratories
        • Speciality Centres

      • UK Outlook (USD Billion, 2018-2030)

      • UK Spinal Needles by Type

        • Pencil-Point Needles
        • Directional Spinal Needles
        • Atraumatic Needles

      • UK Spinal Needles by Application

        • Therapeutic
        • Diagnostic

      • UK Spinal Needles by End User

        • Hospitals & Clinics
        • Diagnostic Centers
        • Research Laboratories
        • Speciality Centres

      • Italy Outlook (USD Billion, 2018-2030)

      • Italy Spinal Needles by Type

        • Pencil-Point Needles
        • Directional Spinal Needles
        • Atraumatic Needles

      • Italy Spinal Needles by Application

        • Therapeutic
        • Diagnostic

      • Italy Spinal Needles by End User

        • Hospitals & Clinics
        • Diagnostic Centers
        • Research Laboratories
        • Speciality Centres

      • Spain Outlook (USD Billion, 2018-2030)

      • Spain Spinal Needles by Type

        • Pencil-Point Needles
        • Directional Spinal Needles
        • Atraumatic Needles

      • Spain Spinal Needles by Application

        • Therapeutic
        • Diagnostic

      • Spain Spinal Needles by End User

        • Hospitals & Clinics
        • Diagnostic Centers
        • Research Laboratories
        • Speciality Centres

      • Rest of Europe Outlook (USD Billion, 2018-2030)

      • Rest of Europe Spinal Needles by Type

        • Pencil-Point Needles
        • Directional Spinal Needles
        • Atraumatic Needles

      • Rest of Europe Spinal Needles by Application

        • Therapeutic
        • Diagnostic

      • Rest of Europe Spinal Needles by End User

        • Hospitals & Clinics
        • Diagnostic Centers
        • Research Laboratories
        • Speciality Centres

    • Asia-Pacific Outlook (USD Billion, 2018-2030)

      • Asia-Pacific Spinal Needles by Type

        • Pencil-Point Needles
        • Directional Spinal Needles
        • Atraumatic Needles

      • Asia-Pacific Spinal Needles by Application

        • Therapeutic
        • Diagnostic

      • Asia-Pacific Spinal Needles by End User

        • Hospitals & Clinics
        • Diagnostic Centers
        • Research Laboratories
        • Speciality Centres

      • China Outlook (USD Billion, 2018-2030)

      • China Spinal Needles by Type

        • Pencil-Point Needles
        • Directional Spinal Needles
        • Atraumatic Needles

      • China Spinal Needles by Application

        • Therapeutic
        • Diagnostic

      • China Spinal Needles by End User

        • Hospitals & Clinics
        • Diagnostic Centers
        • Research Laboratories
        • Speciality Centres

      • Japan Outlook (USD Billion, 2018-2030)

      • Japan Spinal Needles by Type

        • Pencil-Point Needles
        • Directional Spinal Needles
        • Atraumatic Needles

      • Japan Spinal Needles by Application

        • Therapeutic
        • Diagnostic

      • Japan Spinal Needles by End User

        • Hospitals & Clinics
        • Diagnostic Centers
        • Research Laboratories
        • Speciality Centres

      • India Outlook (USD Billion, 2018-2030)

      • India Spinal Needles by Type

        • Pencil-Point Needles
        • Directional Spinal Needles
        • Atraumatic Needles

      • India Spinal Needles by Application

        • Therapeutic
        • Diagnostic

      • India Spinal Needles by End User

        • Hospitals & Clinics
        • Diagnostic Centers
        • Research Laboratories
        • Speciality Centres

      • Australia Outlook (USD Billion, 2018-2030)

      • Australia Spinal Needles by Type

        • Pencil-Point Needles
        • Directional Spinal Needles
        • Atraumatic Needles

      • Australia Spinal Needles by Application

        • Therapeutic
        • Diagnostic

      • Australia Spinal Needles by End User

        • Hospitals & Clinics
        • Diagnostic Centers
        • Research Laboratories
        • Speciality Centres

      • South Korea Outlook (USD Billion, 2018-2030)

      • South Korea Spinal Needles by Type

        • Pencil-Point Needles
        • Directional Spinal Needles
        • Atraumatic Needles

      • South Korea Spinal Needles by Application

        • Therapeutic
        • Diagnostic

      • South Korea Spinal Needles by End User

        • Hospitals & Clinics
        • Diagnostic Centers
        • Research Laboratories
        • Speciality Centres

      • Rest of Asia-Pacific Outlook (USD Billion, 2018-2030)

      • Rest of Asia-Pacific Spinal Needles by Type

        • Pencil-Point Needles
        • Directional Spinal Needles
        • Atraumatic Needles

      • Rest of Asia-Pacific Spinal Needles by Application

        • Therapeutic
        • Diagnostic

      • Rest of Asia-Pacific Spinal Needles by End User

        • Hospitals & Clinics
        • Diagnostic Centers
        • Research Laboratories
        • Speciality Centres

    • Rest of the World Outlook (USD Billion, 2018-2030)

      • Rest of the World Spinal Needles by Type

        • Pencil-Point Needles
        • Directional Spinal Needles
        • Atraumatic Needles

      • Rest of the World Spinal Needles by Application

        • Therapeutic
        • Diagnostic

      • Rest of the World Spinal Needles by End User

        • Hospitals & Clinics
        • Diagnostic Centers
        • Research Laboratories
        • Speciality Centres

      • Middle East Outlook (USD Billion, 2018-2030)

      • Middle East Spinal Needles by Type

        • Pencil-Point Needles
        • Directional Spinal Needles
        • Atraumatic Needles

      • Middle East Spinal Needles by Application

        • Therapeutic
        • Diagnostic

      • Middle East Spinal Needles by End User

        • Hospitals & Clinics
        • Diagnostic Centers
        • Research Laboratories
        • Speciality Centres

      • Africa Outlook (USD Billion, 2018-2030)

      • Africa Spinal Needles by Type

        • Pencil-Point Needles
        • Directional Spinal Needles
        • Atraumatic Needles

      • Africa Spinal Needles by Application

        • Therapeutic
        • Diagnostic

      • Africa Spinal Needles by End User

        • Hospitals & Clinics
        • Diagnostic Centers
        • Research Laboratories
        • Speciality Centres

      • Latin America Outlook (USD Billion, 2018-2030)

      • Latin America Spinal Needles by Type

        • Pencil-Point Needles
        • Directional Spinal Needles
        • Atraumatic Needles

      • Latin America Spinal Needles by Application

        • Therapeutic
        • Diagnostic

      • Latin America Spinal Needles by End User

        • Hospitals & Clinics
        • Diagnostic Centers
        • Research Laboratories
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Related Reports

    Regional Reports
    Country Reports

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials
    Global Magnesium Sulfate Market – Forecast till 2027

    Compare Licence

    ×
    Features License Type
    Single User Multiuser License Enterprise User
    Price $4,950 $5,950 $7,250
    Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
    Free Customization ✓ ✓ ✓
    Direct Access to Analyst ✓ ✓ ✓
    Deliverable Format ✓ ✓ ✓
    Platform Access ✗ ✗ ✓
    Discount on Next Purchase 10% 15% 15%
    Printable Versions ✗ ✗ ✓